Cross section measurements for proton induced reactions on natural La

Becker, K.; Vermeulen, C.; Kutyreff, Christopher J.; O'Brien, Ellen; Morrell, Jonathan T.; Birnbaum, Eva R.; Bernstein, L. A.; Nortier, F.M.; Engle, Jonathan W.

doi:10.1016/j.nimb.2020.02.024

Cited by 9 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The patient is imaged first, establishing the selectivity of the carrier to reach the designated target locations, and so the effectiveness of the therapy when the therapeutic isotope replaces the diagnostic one in the carrier. An example is positron-emitting 134 Ce [125], serving as the theranostic pair for 225 Ac. The former is the first of the rare earths, the latter first of the actinides, both share similar chemical properties.…”

Section: Jinst 18 T05008mentioning

confidence: 99%

High-power Fixed-Field Accelerators

et al. 2023

View full text Add to dashboard Cite

We report the state of the field of High-Power Fixed-Field Accelerators (with an emphasis on cyclotrons) as discussed by international experts during a three-day workshop of the same name in 2021. The workshop was part of the Snowmass'21 Community Planning Exercise. Here, we take stock of the world inventory of high-power fixed-field accelerators, assess available beam currents and beam powers, and investigate limitations. Furthermore, we evaluate the role of these machines in particle physics, directly used or as injectors to other machines, and in industry, as drivers for (medical) isotope production and, potentially, for accelerator-driven systems and sub-critical reactors. Finally, we discuss novel concepts and cutting-edge developments to push the available current higher at several energy scales, thereby increasing relative power. Highlights include new spiral inflector types, direct RFQ injection, H2 + acceleration, utilizing vortex motion, and self-extraction schemes. We also discuss modern computational frameworks to optimize accelerators more efficiently, and better describe the relevant physical processes in simulations.

show abstract

Section: Jinst 18 T05008mentioning

confidence: 99%

High-power Fixed-Field Accelerators

et al. 2023

View full text Add to dashboard Cite

show abstract

“…The cross section data for 139 La(p,x) is more limited than what was available in the niobium case. These available eight channels only contain the three datasets of Tárkányi et al [69], Becker et al [3], and Morrell et al [6],…”

Section: Parameter Adjustment Validationmentioning

confidence: 99%

“…The total derived parameter changes for 139 La(p,x) are listed in Appendix D. The adjusted TALYS fits from this procedure are given in Figures 29-36 compared to the default calculation and EXFOR data for the eight used reaction channels [3,6,69]. Given that the experimental data does not extend beyond 100 MeV, the fits are shown only up to this point.…”

Section: Parameter Adjustment Validationmentioning

confidence: 99%

“…The continued rise of nuclear medicine to study physiological processes, diagnose, and treat diseases requires improved production routes for existing radionuclides, as well as new production pathways for entirely novel radioisotopes [1]. The implementation of these new methodologies or products in nuclear medicine relies on accurate and precise nuclear reaction cross section data in order to properly inform and optimize large scale creation for clinical use [2][3][4][5][6][7]. A primary component in obtaining these data is a suitable reaction monitor, defined as a long-lived radionuclide with a well-known cross section as a function of incident beam energy, that can accurately describe beam properties during a production irradiation [2,5,[8][9][10].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Investigating High-Energy Proton-Induced Reactions on Spherical Nuclei: Implications for the Pre-Equilibrium Exciton Model

Fox,

Voyles,

Morrell

et al. 2020

Preprint

View full text Add to dashboard Cite

Extension of recommended cross section database for production of therapeutic isotopes

Tárkányi,

Hermanne,

Ignatyuk

et al. 2024

J Radioanal Nucl Chem

View full text Add to dashboard Cite

Radionuclide-based diagnostics and therapy require proper selection of production nuclear reaction based on knowledge of the production excitation functions and the achievable yields completed with data on the formation of possible impurities. In the present work the existing IAEA recommended cross section data database for production of therapeutic isotopes is extended to production of the 47Sc,47Ca(47Sc), 58mCo, 71As(71Ge), 71Ge, 77Br, 77Kr(77Br), 80mBr, 103Pd, 103Pd(103mRh), 103Ru(103mRh), 105Rh, 117mSn, 119Sb, 119mTe(119Sb), 134Ce, 135La, 149gTb, 161Tb, 165Er, 165Tm(165Er), 167Tm, 197mHg, 197gHg, 198gAu, and 230Pa(230U) radioisotopes. Nearly 60 nuclear reactions are presented and discussed. The new recommended cross-section data and their uncertainties for the production of these 21 radionuclides will be available on the Web page of the IAEA Nuclear Data Section at https://nds.iaea.org/radionuclides and also at the IAEA medical portal https://nds.iaea.org/medportal.

show abstract

Cross section measurements for proton induced reactions on natural La

Cited by 9 publications

References 12 publications

High-power Fixed-Field Accelerators

High-power Fixed-Field Accelerators

Investigating High-Energy Proton-Induced Reactions on Spherical Nuclei: Implications for the Pre-Equilibrium Exciton Model

Extension of recommended cross section database for production of therapeutic isotopes

Contact Info

Product

Resources

About